SKŘIČKOVÁ, Jana, Lenka BABIČKOVÁ, Marcela TOMÍŠKOVÁ and Bohdan KADLEC. Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonselected population. In ASCO - Chicago. 2010.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonselected population
Authors SKŘIČKOVÁ, Jana (203 Czech Republic, guarantor, belonging to the institution), Lenka BABIČKOVÁ (203 Czech Republic, belonging to the institution), Marcela TOMÍŠKOVÁ (203 Czech Republic, belonging to the institution) and Bohdan KADLEC (203 Czech Republic, belonging to the institution).
Edition ASCO - Chicago, 2010.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30203 Respiratory systems
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/10:00046791
Organization unit Faculty of Medicine
Keywords in English Vinorelbine; carboplatine; NSCLC treatment
Changed by Changed by: prof. MUDr. Jana Skřičková, CSc., učo 1808. Changed: 19/1/2011 14:04.
Abstract
The use of intravenous vinorelbine (NVBiv) on D1 and oral vinorelbine (NVBo) on D8 in combination with carboplatin (CBDCA) as first-line treatment in advanced non-small lung cancer (NSCLC) patients: results of a prospective study in nonselected population are reported.
Links
MSM 141100003, plan (intention)Name: Zevní prostředí - karcinogeneze - onkologie
Investor: Ministry of Education, Youth and Sports of the CR, Environment - carcinogenesis - oncology
PrintDisplayed: 1/8/2024 00:29